|
Volume 272, Number 31,
Issue of August 1, 1997
pp. 19525-19531
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Insulin and Interleukin-4 Induce Desensitization to the Mitogenic
Effects of Insulin-like Growth Factor-I
PIVOTAL ROLE FOR INSULIN RECEPTOR SUBSTRATE-2
(Received for publication, April 4, 1997, and in revised form, May 15, 1997)
Tufia C.
Haddad
and
Cheryl A.
Conover
From the Endocrine Research Unit, Mayo Clinic and Mayo Foundation,
5-164 W. Joseph, Rochester, Minnesota 55905
Insulin-induced desensitization to insulin-like
growth factor-I (IGF-I) stimulated mitogenesis in bovine fibroblasts
involves steps distal to IGF-I binding to its tyrosine kinase receptor. When quiescent cultures of bovine fibroblasts were stimulated with 10 nM IGF-I and total cell lysates immunoblotted with
anti-phosphotyrosine antibody, we observed a band at ~97 kDa,
representing the -subunit of the IGF-I receptor, and a predominant
tyrosyl-phosphorylated species migrating as a broad band between 170 and 190 kDa. The majority of proteins in this latter band were
immunoprecipitated by antibodies against insulin receptor substrate
(IRS)-2 and not by antibodies against IRS-1. Pretreatment of bovine
fibroblasts with 10 nM insulin for 48 h blocked
subsequent IGF-I-stimulated DNA synthesis and the IGF-I-induced
increase in tyrosyl-phosphorylated IRS-2. Insulin pretreatment did not
alter IRS-1 or IRS-2 expression by these cells, as assessed by
metabolic labeling and direct immunoblotting with IRS antibodies. The
interleukin-4 (IL-4) cytokine receptor also has IRS-2 as its major
substrate for tyrosine phosphorylation. Although 10 nM IL-4
was as effective as 10 nM IGF-I in stimulating IRS-2
phosphorylation, 10 nM IL-4 did not have comparable
mitogenic power in these cells. Nonetheless, pretreatment of bovine
fibroblasts with IL-4 inhibited IGF-I-stimulated DNA synthesis by
50-60%, concomitant with a decrease in IGF-I-induced IRS-2
phosphorylation. Insulin-induced desensitization could be prevented if
a specific inhibitor of phosphatidylinositol 3-kinase (LY294002), but
not an inhibitor of mitogen-activated protein kinase (PD98059), was present during the preincubation period. LY294002 also prevented the
shift in IRS-2 molecular mass in response to prolonged incubation of
cells with insulin. These data indicate that, in a nontransformed cell
system, IRS-2 plays a key role in cellular desensitization to
IGF-I-stimulated mitogenesis most likely through a feedback mechanism
in the phosphatidylinositol 3-kinase pathway. Furthermore, they suggest
that signaling through IRS-2 may provide an important point of
integration for hormone, growth factor, and cytokine receptor systems
that regulate critical cellular growth responses.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. E. Hartman, J. C. O'Connor, J. P. Godbout, K. D. Minor, V. R. Mazzocco, and G. G. Freund
Insulin Receptor Substrate-2-dependent Interleukin-4 Signaling in Macrophages Is Impaired in Two Models of Type 2 Diabetes Mellitus
J. Biol. Chem.,
July 2, 2004;
279(27):
28045 - 28050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Dalle, T. Imamura, D. W. Rose, D. S. Worrall, S. Ugi, C. J. Hupfeld, and J. M. Olefsky
Insulin Induces Heterologous Desensitization of G Protein-Coupled Receptor and Insulin-Like Growth Factor I Signaling by Downregulating {beta}-Arrestin-1
Mol. Cell. Biol.,
September 1, 2002;
22(17):
6272 - 6285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Kalli, O. I. Falowo, L. K. Bale, M. A. Zschunke, P. C. Roche, and C. A. Conover
Functional Insulin Receptors on Human Epithelial Ovarian Carcinoma Cells: Implications for IGF-II Mitogenic Signaling
Endocrinology,
September 1, 2002;
143(9):
3259 - 3267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Conover, L. K. Bale, S. K. Durham, and D. R. Powell
Insulin-Like Growth Factor (IGF) Binding Protein-3 Potentiation of IGF Action Is Mediated through the Phosphatidylinositol-3-Kinase Pathway and Is Associated with Alteration in Protein Kinase B/AKT Sensitivity
Endocrinology,
September 1, 2000;
141(9):
3098 - 3103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Lee, J. L. Gooch, S. Oesterreich, R. L. Guler, and D. Yee
Insulin-Like Growth Factor I-Induced Degradation of Insulin Receptor Substrate 1 Is Mediated by the 26S Proteasome and Blocked by Phosphatidylinositol 3'-Kinase Inhibition
Mol. Cell. Biol.,
March 1, 2000;
20(5):
1489 - 1496.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Li, G. Sweeney, Q. Wang, and A. Klip
Participation of PI3K and atypical PKC in Na+-K+-pump stimulation by IGF-I in VSMC
Am J Physiol Heart Circ Physiol,
June 1, 1999;
276(6):
H2109 - H2116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, K. DeFea, and R. A. Roth
Modulation of Insulin Receptor Substrate-1 Tyrosine Phosphorylation by an Akt/Phosphatidylinositol 3-Kinase Pathway
J. Biol. Chem.,
April 2, 1999;
274(14):
9351 - 9356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Richards, M. P. Walker, J. Sebastian, and R. P. DiAugustine
Insulin-like Growth Factor-1 (IGF-1) Receptor-Insulin Receptor Substrate Complexes in the Uterus. ALTERED SIGNALING RESPONSE TO ESTRADIOL IN THE IGF-1m/m MOUSE
J. Biol. Chem.,
May 8, 1998;
273(19):
11962 - 11969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Valverde, T. Teruel, P. Navarro, M. Benito, and M. Lorenzo
Tumor Necrosis Factor-{alpha} Causes Insulin Receptor Substrate-2-Mediated Insulin Resistance and Inhibits Insulin-Induced Adipogenesis in Fetal Brown Adipocytes
Endocrinology,
March 1, 1998;
139(3):
1229 - 1238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. De Fea and R. A. Roth
Modulation of Insulin Receptor Substrate-1 Tyrosine Phosphorylation and Function by Mitogen-activated Protein Kinase
J. Biol. Chem.,
December 12, 1997;
272(50):
31400 - 31406.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|